Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species. - Wikidata - awgldk - TriplyDB

Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species.

Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species.

http://www.wikidata.org/entity/Q33888492

about

The Function and Roles of ADAMTS-7 in Inflammatory Diseases Landmarks in prostate cancer diagnosis: the biomarkers Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy A role for novel adipose tissue-secreted factors in obesity-related carcinogenesis.Combined treatment of PC-3 cells with ultrasound and microbubbles suppresses invasion and migration ADAMTS-12: a multifaced metalloproteinase in arthritis and inflammation Matrilin-1 is an inhibitor of neovascularization.Potential new urinary markers in the early detection of bladder cancer.Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer.Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshells.Tcf3 promotes cell migration and wound repair through regulation of lipocalin 2.ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner.Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort.Raf-induced MMP9 disrupts tissue architecture of human breast cells in three-dimensional culture and is necessary for tumor growth in vivo.The biochemical value of urinary metalloproteinases 3 and 9 in diagnosis and prognosis of bladder cancer in Egypt.Urinary high molecular weight matrix metalloproteinases as non-invasive biomarker for detection of bladder cancer.Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease.ADAMTS-7 exhibits elevated expression in cartilage of osteonecrosis of femoral head and has a positive correlation with TNF- α and NF- κ B P65 Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma.Specific activation of K-RasG12D allele in the bladder urothelium results in lung alveolar and vascular defects.Age-dependent loss of MMP-3 in Hutchinson-Gilford progeria syndrome Urine matrix metalloproteinases (MMPs) as biomarkers for the progression of fracture healing Potential of fluorescent metalloproteinase substrates for cancer detection Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.Profilin 1 is a potential biomarker for bladder cancer aggressiveness HCRP-1 regulates cell migration and invasion via EGFR-ERK mediated up-regulation of MMP-2 with prognostic significance in human renal cell carcinoma Evaluation of MMP-2, MMP-9, TIMP-1, TIMP-2, NGAL and MMP-9/NGAL complex in urine and sera from patients with bladder cancer.Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer.The endogenous zinc finger transcription factor, ZNF24, modulates the angiogenic potential of human microvascular endothelial cells.Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation.The present and future of prostate cancer urine biomarkers.Effects of ectopic expression of NGAL on doxorubicin sensitivity.Sol narae (Sona) is a Drosophila ADAMTS involved in Wg signaling Markers for detection of prostate cancer.The role of ADAMTS-7 and ADAMTS-12 in the pathogenesis of arthritis.The emerging roles of ADAMTS-7 and ADAMTS-12 matrix metalloproteinases.Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

P2860

Q26773190-DECF25F3-DADE-4610-93D2-A9D056C02911 Q26852523-EDFF5477-E2E1-4E9B-A11D-4605DB51C973 Q28068137-729D4161-CE93-4EE3-A66F-5313E83E58D3 Q30384899-65C0340B-60C4-4909-9DFE-BFF37ECA0BBD Q30433092-11F5BE3E-BA5F-401B-9F13-C2AD3487302A Q33607501-FED01D3A-B6D0-498D-B851-60452392A790 Q33619544-00DD835C-C22E-4DF5-A164-161BA7FB0F89 Q33657098-D598129C-A145-482C-B594-4FC0E3317E2F Q33688934-3CD55318-A710-4DBF-BDB6-1AEAC99E1C60 Q33735020-7B51B3E5-E19C-4FDC-A4E1-7776D6C68658 Q33736914-21427C4D-0582-4B1F-BEC0-A861F875B086 Q33925776-C3001948-1026-4F82-83AF-04A2F6D79CF3 Q33990834-CE1B6B3B-217D-4F11-BFE8-7D0F85E9BB2A Q34135237-470F719F-D94A-4533-AC7D-7E6963DCE532 Q34411893-8AC0972E-AFD6-4AA1-A832-D3CFBEABC35B Q34544450-8D4D9D2D-470B-428A-A2DE-9E3693D6A10B Q34721798-CBDCC282-B003-46A2-9643-F04E287FFA5C Q34755816-622D37B6-8A22-4225-B5E9-0C7B81CD9395 Q35026762-9AC73AF9-7D98-43E1-97E1-83023674B493 Q35152357-278FD294-84CD-48AE-A08E-34126CDF147C Q35156169-475509AD-16E4-4378-A14E-61224D7C4B1B Q35349300-9F402A2D-BDE1-45E8-9B67-27CDC00F464C Q35350100-88F2F0DA-E2F7-4CF8-8B07-1D111DD0F6CB Q35597564-99B1716B-A0C0-4D7C-A012-F6538A0C8780 Q35678051-B7786A44-75F0-4DFE-B0C0-9FE7FE574898 Q35878733-6871FCFF-7F64-438A-9E18-46D642143E52 Q35992848-2935F080-6C3E-42E0-AF4E-CF66A8231901 Q36085915-3866FE2D-25F3-43B1-9555-979687B231EA Q36190604-D5908383-8415-4148-929E-66D9F413B3CF Q36455680-1271EF2A-CACC-4607-9A1B-432178652E00 Q36525804-5476A6E0-7E13-4084-82B3-20F4CD177067 Q36556350-07AB5294-842F-483D-9E45-74452173B02D Q36796256-23391F30-9CA5-4257-803A-82B440DAF262 Q37007392-E2B11B0D-2D63-43B5-8D45-1B5CAFF00E04 Q37031268-01AC0D1A-B24F-4B27-BE09-A7BBBF13F1EA Q37184855-5AC3810B-7AC1-4AC3-9ACE-80502503B4DD Q37328403-01AA25B5-5872-4094-934B-DB2A51494E12 Q37355734-EF036799-3976-4946-9C26-7B801EA450FC Q37358106-E85888AD-8828-4ED2-9B4D-A8E6A91F5E5D Q37412311-4BE94566-1267-4F12-AE67-FC2D6DA80395

P2860

Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species.

http://www.wikidata.org/entity/Q33888492

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Tumor-specific urinary matrix ...... rix metalloproteinase species.

@ast

Tumor-specific urinary matrix ...... rix metalloproteinase species.

@en

type

label

Tumor-specific urinary matrix ...... rix metalloproteinase species.

@ast

Tumor-specific urinary matrix ...... rix metalloproteinase species.

@en

prefLabel

Tumor-specific urinary matrix ...... rix metalloproteinase species.

@ast

Tumor-specific urinary matrix ...... rix metalloproteinase species.

@en

P1433

Q33888492-15935809-172F-43C0-A77B-698B22575044

P1476

Q33888492-7E372AD8-3848-4EE8-A1B2-0CA191603CCA

P2093

Q33888492-0DE742C0-72A4-4F9C-BD1F-0FCE1E02D532

Q33888492-241A0614-B1A0-4319-B32F-BFE63B87733D

Q33888492-2BD3D136-D21A-49E6-A193-01A6E8FA6D06

Q33888492-855D89CE-CA6C-48CE-83F4-435DF568B6F8

Q33888492-D47A60C7-07EB-4175-8314-C61F3F7726F4

Q33888492-D6D0E30D-ACF0-46F9-8614-A81D256EB675

Q33888492-EAE7938A-2557-4F37-B800-2B288CCF89E6

P2860

Q33888492-0B75E4D4-7D93-460D-9BDE-BEE0E49EF0C9

Q33888492-1C4E2A04-BA30-4A71-9978-A963030C6F9E

Q33888492-2BE6A9E5-8CFB-4BF5-B521-D0ACC7662974

Q33888492-36FED708-3569-4FFF-A44F-0CE60776C528

Q33888492-3EB53C53-19ED-4179-9BDE-B36B4FED5923

Q33888492-3EC10C20-22E3-455C-94DC-D47C5BFABDFF

Q33888492-5F37C581-2E08-4734-B261-AD2755FD6250

Q33888492-6974AD43-42E3-4829-8D29-E83854DEEFAA

Q33888492-69BD3867-8F8C-4ED1-9AD9-1ADE7F3F2E90

Q33888492-7258A831-1E67-4942-86E5-34D91170D6CB

P304

Q33888492-0AC26700-576B-4F4A-BE2A-2EF84B8C4648

P31

Q33888492-689320BC-326A-47CA-A79C-BA99AB44E0B1

P356

Q33888492-BC668391-EA71-4D6E-8C40-4FD0A92E12A8

P407

Q33888492-28CD0367-9B21-4AE1-A769-B4F77FF2A79E

P433

Q33888492-40857609-6C34-4F29-8006-B1EFB79A0E9B

P478

Q33888492-DB616718-DCF8-4D94-89E7-24238ADBAA14

P50

Q33888492-F26593D9-C30B-41A0-92EF-E145A0836208

P577

Q33888492-D28782A4-7607-40E4-B037-AAFF0BB44BA7

P5875

Q33888492-E5B03756-C547-472E-AC2F-055D84787C4F

P698

Q33888492-5B9417FE-9C64-4310-AFC7-D942E4088E3F

P932

Q33888492-0790950A-7A02-453D-8589-D84701CDC3B9

P356

1078-0432.CCR-08-1136

P1433

Clinical Cancer Research

P1476

Tumor-specific urinary matrix ...... rix metalloproteinase species.

@en

P2093

Carolyn C Lamb

http://www.w3.org/2001/XMLSchema#string

Dmitri Wiederschain

http://www.w3.org/2001/XMLSchema#string

Gwendolyn Louis

http://www.w3.org/2001/XMLSchema#string

Kevin R Loughlin

http://www.w3.org/2001/XMLSchema#string

Marsha A Moses

http://www.w3.org/2001/XMLSchema#string

Roopali Roy

http://www.w3.org/2001/XMLSchema#string

Susan M Kilroy

http://www.w3.org/2001/XMLSchema#string

P2860

Matrix metalloproteinases

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family

Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin

New functions for the matrix metalloproteinases in cancer progression

Plasma matrix metalloproteinase 9 as biomarker of prostate cancer progression in Dunning (Copenhagen) rats.

ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage.

Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers.

Matrix metalloproteinases and metastasis.

Matrix metalloproteinases in tumour invasion and metastasis.

P304

6610-6617

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-08-1136

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

David Zurakowski

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23389204

http://www.w3.org/2001/XMLSchema#string

P698

18927302

http://www.w3.org/2001/XMLSchema#string

P932

2879331

http://www.w3.org/2001/XMLSchema#string